NIR‐II Fluorescence Imaging‐guided Photothermal Activated Pyroptosis For Precision Therapy Of Glioma
ChemBioChem · 2025
DOI: 10.1002/cbic.202400804 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Zhuang Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Molecular Imaging and Translational Medicine (MITM), Engineering Research Center of Molecular & Neuro-imaging, Ministry of Education, School o…. Hauptthemen laut MEDLINE: Pyroptosis, Glioma, Optical Imaging, Photothermal Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The resistance of cancer cells to apoptosis poses a significant challenge in cancer therapy, driving the exploration of alternative cell death pathways such as pyroptosis, known for its rapid and potent effects. While initial efforts focused on chemotherapy‐induced pyroptosis, concerns about systemic inflammation highlight the need for precise activation strategies. Photothermal therapy emerges as a promising non‐invasive technique, minimizing pyroptosis‐related side effects by targeting tumors spatially and temporally. However, accurately pinpointing tumors to avoid collateral damage remains a challenge. Thus, we utilize NIR‐II fluorescence imaging to achieve precise PTT‐induced pyroptosis activation in glioma. A polymer semiconductor‐based PTT agent was developed with high optical stability, integrated with mesoporous silica to enhance its biocompatibility. These nanoparticles, stabilized through PEG modification and targeted with cRGD peptides, effectively induced pyroptosis in vitro . Furthermore, this design facilitated precise tumor imaging guidance and subsequent pyroptosis activation in vivo , presenting a promising strategy for glioma therapy with minimized adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lab of Molecular Imaging and Translational Medicine (MITM), Engineering Research Center of Molecular & Neuro-imaging, Ministry of Education, School of Life Science and Technology, Xidian University, Xi'an, Shaanxi, 7101…
ORCID-Profile: Zhongliang Wang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Shaanxi Fundamental Science Research Project for Chemistry and Biology
- Natural Science Basic Research Program of Shaanxi
- Postdoctoral Research Project of Shaanxi Province
- Innovation Capability Support Program of Shaanxi
- Dual-chain Integration Special Program of Qin Chuang Yuan Construction
Zitieren
APA
Chen, Z., Luo, Y., Jia, Q., Yang, Z., Liu, Z., Cui, C., Qiao, C., Yang, P., & Wang, Z. (2025). NIR‐II Fluorescence Imaging‐guided Photothermal Activated Pyroptosis For Precision Therapy Of Glioma. ChemBioChem. https://doi.org/10.1002/cbic.202400804
Vancouver
Chen Z, Luo Y, Jia Q, Yang Z, Liu Z, Cui C, et al. NIR‐II Fluorescence Imaging‐guided Photothermal Activated Pyroptosis For Precision Therapy Of Glioma. ChemBioChem. 2025. doi:10.1002/cbic.202400804
BibTeX
@article{Chen2025,
author = {Chen, Zhuang and Luo, Yi and Jia, Qian and Yang, Zuo and Liu, Zebing and Cui, Can and Qiao, Chaoqiang and Yang, Peng and Wang, Zhongliang},
title = {NIR‐II Fluorescence Imaging‐guided Photothermal Activated Pyroptosis For Precision Therapy Of Glioma},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202400804}
}
EUVIMED